Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia

Nursing and Health Professions

• Cohort Analysis 20%
• Community Acquired Pneumonia 80%
• Confidence Interval 40%
• Dipeptidyl Carboxypeptidase Inhibitor 100%
• Drug Therapy 40%
• Electric Potential 20%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 80%
• Infection 20%
• Inpatient 40%
• Mortality 80%
• Odds Ratio 40%
• Outpatient 40%
• Outpatient Care 20%
• Pneumonia 20%
• Statin (Protein) 20%

Medicine and Dentistry

• ACE Inhibitor 100%
• Age 20%
• Association 20%
• Cohort Analysis 20%
• Infection 20%
• Male 40%
• Mortality 80%
• Odds Ratio 40%
• Pneumonia 20%
• Randomized Controlled Trial 40%
• Veterans Affairs 40%

Pharmacology, Toxicology and Pharmaceutical Science

• Community Acquired Pneumonia 80%
• Confounder 20%
• Dipeptidyl Carboxypeptidase Inhibitor 100%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 80%
• Infection 20%
• Mortality 80%
• Pneumonia 20%
• Statin (Protein) 20%